← Back to Clinical Trials
Recruiting NCT06434337

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Human Papillomavirus
Sponsor M.D. Anderson Cancer Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex FEMALE
Min Age 21 Years
Max Age N/A
Start Date 2024-07-23
Completion 2026-03-31
Interventions
Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test")

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

Eligibility Criteria

Inclusion Criteria: 1. People with a cervix 21 years of age or older. 2. Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy. 3. Willing and able to provide informed consent. 4. Able to perform protocol-required activities. Able to speak and read English or Spanish. Exclusion Criteria 1. Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy. 2. Participant or provider decision not to collect a sample for this study. 3. Participants that are pregnant.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}